האם דיכאון הוא מחלה דלקתית ומה ניתן לעשות כדי לשפר את המצב?

מקורות

1. https://www.nature.com/articles/s41380-022-01661-0

2. Beurel E, Toups M, Nemeroff CB. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020;107(2):234-256. doi:10.1016/j.neuron.2020.06.002

3. Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation: depression fans the flames and feasts on the heat. Am J Psychiatry. 2015 Nov 1;172(11):1075-91. doi: 10.1176/appi.ajp.2015.15020152. Epub 2015 Sep 11. PMID: 26357876; PMCID: PMC6511978.

4. ed SA, Beurel E, Loewenstein DA, Lowell JA, Craighead WE, Dunlop BW, Mayberg HS, Dhabhar F, Dietrich WD, Keane RW, et al. (2018). Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response. Neuron 99, 914–924.e3.

5. Slavich GM, Irwin MR: From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 2014; 140:774–815

6. Miller AH, Haroon E, Raison CL, et al.: Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 2013; 30:297–306

7.Dantzer R, O’Connor JC, Freund GG, et al.: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9:46–56

8.Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27:24–31

9.DellaGioia N, Hannestad J: A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev 2010; 34:130–143

10. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27:24–31

11. Capuron L, Miller AH: Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011; 130:226–238

12. Bull SJ, Huezo-Diaz P, Binder EB, et al.: Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry 2009; 14:1095–1104

13. Udina M, Moreno-España J, Navinés R, et al.: Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms. Psychoneuroendocrinology 2013; 38:1803–1813

14. Udina M, Castellví P, Moreno-España J, et al.: Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 2012; 73:1128–1138

15. Dobbin JP, Harth M, McCain GA, Martin RA, Cousin K: Cytokine production and lymphocyte transformation during stress. Brain Behav Immun. 1991, 5: 339-348.

16. Mittwoch-Jaffe T, Shalit F, Srendi B, Yehuda S: Modification of cytokine secretion following mild emotional stimuli. Neuroreport. 1995, 6: 789-792

17. Deinzer R, Forster P, Fuck L, Herforth A, Stiller-Winkler R, Idel H: Increase of crevicular interleukin 1beta under academic stress at experimental gingivitis sites and at sites of perfect oral hygiene. J Clin Periodontol. 1999, 26: 1-8.

18. Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpé S, Smith RS: The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 1998, 10: 313-318.

19. Song C, Kenis G, van Gastel A, Bosmans E, Lin A, de Jong R, Neels H, Scharpe S, Janca A, Yasukawa K, Maes M: Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatry Res. 1999, 85: 293-30

20. Mayer EA, Knight R, Mazmanian SK, et al.: Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 2014; 34:15490–15496

21. Maes M, Kubera M, Leunis JC: The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinol Lett 2008; 29:117–124

22. 31.Moylan S, Maes M, Wray NR, Berk M: The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2012, 18: 595-606.

23. Leonard B, Maes M: Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012, 36: 764-785.

24. Maes M, Kubera M, Leunis JC, Berk M, Geffard M, Bosmans E: In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand. 2013, 127: 344-354.

25. Dinan TG, Stanton C, Cryan JF: Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013; 74:720–726

26. Drewnowski A, Popkin BM: The nutrition transition: new trends in the global diet.
Nutr Rev. 1997, 55: 31-43.

27. Rahe C, Unrath M, Berger K: Dietary patterns and the risk of depression in adults: a systematic review of observational studies. Eur J Nutr 2014; 53:997–1013

28. Lai JS, Hiles S, Bisquera A, et al.: A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am J Clin Nutr 2014; 99:181–197

29. Sánchez-Villegas A, Delgado-Rodríguez M, Alonso A, et al.: Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry 2009; 66:1090–1098

30. Rienks J, Dobson AJ, Mishra GD: Mediterranean dietary pattern and prevalence and incidence of depressive symptoms in mid-aged women: results from a large community-based prospective study. Eur J Clin Nutr 2013; 67:75–82

31. Lopez-Garcia E, Schulze MB, Fung TT, Meigs JB, Rifai N, Manson JE, Hu FB: Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2004, 80: 1029-1035.

32. Fung TT, Rimm EB, Spiegelman D, Rifai N, Tofler GH, Willett WC, Hu FB: Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr. 2001, 73: 61-67.

33. Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C: Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol. 2004, 44: 152-158.

34. Conn VS: Depressive symptom outcomes of physical activity interventions: meta-analysis findings. Ann Behav Med. 2010, 39: 128-138.

35. Greist JH, Klein MH, Eischens RR, Faris J, Gurman AS, Morgan WP: Running as treatment for depression. Compr Psychiatry. 1979, 20: 41-54.

36. Pasco JA, Williams LJ, Jacka FN, Henry MJ, Coulson CE, Brennan SL, Leslie E, Nicholson GC, Kotowicz MA, Berk M: Habitual physical activity and the risk for depressive and anxiety disorders among older men and women. Int Psychogeriatr. 2011, 23: 292-298.

37. Strawbridge WJ, Deleger S, Roberts RE, Kaplan GA: Physical activity reduces the risk of subsequent depression for older adults. Am J Epidemiol. 2002, 156: 328-334.

38.Brown WJ, Ford JH, Burton NW, Marshall AL, Dobson AJ: Prospective study of physical activity and depressive symptoms in middle-aged women. Am J Prev Med. 2005, 29: 265-272.

39. Lancaster GI, Febbraio MA: The immunomodulating role of exercise in metabolic disease. Trends Immunol 2014; 35:262–269

40. Gleeson M, Bishop NC, Stensel DJ, et al.: The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011; 11:607–615

41.Trivedi MH, Greer TL, Church TS, et al.: Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry 2011; 72:677–684ֿ

42. Shelton RC, Miller AH: Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 2010; 91:275–299

43. Luppino FS, de Wit LM, Bouvy PF, et al.: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67:220–229

44. Kyrou I, Chrousos GP, Tsigos C: Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci 2006; 1083:77–110

45. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C: The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis. 2005, 183: 308-315.

46. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA: Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun. 2003, 17: 276-285.

47. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH: Smoking and mental illness: a population-based prevalence study. JAMA. 2000, 284: 2606-2610.

48. Lawrence D, Mitrou F, Zubrick SR: Smoking and mental illness: results from population surveys in Australia and the United States. BMC Publ Health. 2009, 9: 285.

49. Pasco JA, Williams LJ, Jacka FN, Ng F, Henry MJ, Nicholson GC, Kotowicz MA, Berk M: Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry. 2008, 193: 322-326.

50. Boden JM, Fergusson DM, Horwood LJ: Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry. 2010, 196: 440-446.

51.Chaiton MO, Cohen JE, O’Loughlin J, Rehm J: A systematic review of longitudinal studies on the association between depression and smoking in adolescents. BMC Publ Health. 2009, 9: 356.

52. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF: Systemic effects of smoking. Chest. 2007, 131: 1557-1566

53. Moylan S, Maes M, Wray NR, Berk M: The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2012, 18: 595-606

54. Adeniyi AA, Ola BA, Edeh CE, Ogunbanjo BO, Adewuya AO: Dental status of patients with mental disorders in a Nigerian teaching hospital: a preliminary survey. Spec Care Dentist. 2011, 31: 134-137.

55. Okoro CA, Strine TW, Eke PI, Dhingra SS, Balluz LS: The association between depression and anxiety and use of oral health services and tooth loss. Community Dent Oral Epidemiol. 2012, 40: 134-144

56. Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA: Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol. 2003, 23: 1245-1249.

57. Fang H, Tu S, Sheng J, Shao A. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med. 2019;23(4):2324-2332. doi:10.1111/jcmm.14170

58. Irwin MR: Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol 2015; 66:143–172

59. Lopresti AL, Hood SD, Drummond PD: A review of lifestyle factors that
contribute to important pathways associated with major depression: diet,
sleep, and exercise. J Affect Disord 2013; 148:12–27

60. Raison CL, Rye DB, Woolwine BJ, et al.: Chronic interferon-alpha
administration disrupts sleep continuity and depth in patients with hepatitis
C: association with fatigue, motor slowing, and increased evening cortisol. Biol
Psychiatry 2010; 68:942–949

61.Fanzen P, Buysse D: Sleep disturbances and depression: risk
relationships for subsequent depression and therapeutic implications.
Dialogues Clin Neurosci. 2008, 10: 473-481.

62. Bower B, Bylsma LM, Morris BH, Rottenberg J: Poor reported sleep quality
predicts low positive affect in daily life among healthy and mood-
disordered persons. J Sleep Res. 2010, 19: 323-332.

63. Turek F: Insomnia and depression: if it looks and walks like a duck. Sleep
Res Online. 2005, 28: 1457-1464
64. Pasco JA, Henry MJ, Nicholson GC, Sanders KM, Kotowicz MA: Vitamin D status of women in the Geelong osteoporosis study: association with diet and casual exposure to sunlight. Med J Aust. 2001, 175: 401-405.

65. Eyles D, Burne T, McGrath J: Vitamin D in fetal brain development. Semin Cell Dev Biol. 2011, 22: 629-63

66. Berk, M., Williams, L.J., Jacka, F.N. et al. So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med 11, 200 (2013). ֿ

67.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970300/

68. Lansdowne AT, Provost SC: Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl). 1998, 135: 319-323.

69. Grossmann RE, Zughaier SM, Liu S, Lyles RH, Tangpricha V: Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr. 2012, 66: 1072-1074.

70. Faridar A, Eskandari G, Sahraian MA, Minagar A, Azimi A: Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurol Belg. 2012, 112: 327-333.

71. Lin PY, Huang SY, Su KP: A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010; 68:140–147

72.Giles GE, Mahoney CR, Kanarek RB: Omega-3 fatty acids influence mood in healthy and depressed individuals. Nutr Rev 2013; 71:727–741

73. Pittet YK, Berger MM, Pluess TT, et al.: Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil. Intensive Care Med 2010; 36:289–295

74.Pluess TT, Hayoz D, Berger MM, et al.: Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med 2007; 33:789–797